3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with pd 174494 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HM; Chang, SY; Chen, GD; Chiu, CH; Chou, D; Lai, CY; Lee, SD; Lin, TB; Peng, HY; Tung, KC | 1 |
1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and pd 174494
Article | Year |
---|---|
Orexin-A modulates glutamatergic NMDA-dependent spinal reflex potentiation via inhibition of NR2B subunit.
Topics: Action Potentials; Animals; Electromyography; Excitatory Amino Acid Antagonists; Female; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; N-Methylaspartate; Neurons, Afferent; Neuropeptides; Orexins; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reflex; Spinal Cord; Synaptic Transmission; Urethra | 2008 |